"Seit mehr als 125 Jahren forscht MSD an Arzneimitteln und Impfstoffen zur Bekämpfung der weltweit bedeutendsten Erkrankungen – mit der Mission, die Welt und das Leben von Menschen und Tieren zu verbessern. Das Unternehmen setzt sich aus Überzeugung für die Gesundheit der Patienten und der Bevölkerung ein, indem es den Zugang zu Versorgungslösungen durch langfristige Strategien, Programme und Partnerschaften verbessert. Heute ist MSD führend in der Forschung zur Vorbeugung und Behandlung von Krankheiten, die Menschen und Tiere bedrohen – darunter Krebs, Infektionskrankheiten wie HIV und Ebola sowie neue Tierkrankheiten – mit dem Anspruch, das weltweit führende forschende biopharmazeutische Unternehmen zu sein."

During the past decade, MSD Sharp & Dohme GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MSD Sharp & Dohme GmbH" are "Advanced Cancer" (1 trials), "Advanced Solid Tumors" (1 trials), "Anal Cancer" (1 trials), "Anal Carcinoma" (1 trials) and "Bile Duct Cancer" (1 trials). Many other conditions were trialed in "MSD Sharp & Dohme GmbH" in a lesser frequency.

Most popular intervention types in "MSD Sharp & Dohme GmbH" are "Drug" (4 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone acetate 1000 mg" (1 trials), "Belzutifan 120mg" (1 trials), "Carboplatin" (1 trials), "Dexamethasone 8 mg" (1 trials) and "Docetaxel 75 mg/m^2" (1 trials). Other intervention names were less common.

The vast majority of trials in "MSD Sharp & Dohme GmbH" are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MSD Sharp & Dohme GmbH". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in MSD Sharp & Dohme GmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MSD Sharp & Dohme GmbH, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".